Prevention of Tumorigenesis in p53-Null Mammary Epithelium by Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib, and Celecoxib
Cancer Prev Res Medina et al.
2: 168
Related Article
The following related article is available for this article:
Identification of Modulated Genes by Three Classes of Chemopreventive Agents at Preneoplastic Stages in a p53-Null Mouse Mammary Tumor Model
Martín C. Abba, Yuhui Hu, Carla C. Levy, Sally Gaddis, Frances S. Kittrell, Jamal Hill, Reid P. Bissonnette, Powel H. Brown, Daniel Medina and C. Marcelo Aldaz